145 related articles for article (PubMed ID: 806271)
21. Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy.
Doherty M; Richards N; Hornby J; Powell R
Ann Rheum Dis; 1988 Mar; 47(3):190-7. PubMed ID: 2833185
[TBL] [Abstract][Full Text] [Related]
22. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
23. [Study of the synovial fluid in rheumatoid arthritis].
Zakharova MM; Alekberova ZS; Trofimova TM; Riazantseva TA
Ter Arkh; 1988; 60(7):79-84. PubMed ID: 3212745
[TBL] [Abstract][Full Text] [Related]
24. [Alpha-2 macroglobulin in serum and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis].
Kolarov Z; Stoilov R; Baleva M; Nikolov K; Sheĭtanov I; Iancheva M; Tsacheva N; Radenska-Lopovok S
Ter Arkh; 2000; 72(5):17-9. PubMed ID: 11109611
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and humoral studies of seronegative rheumatoid arthritis. I].
Suţeanu S; Ciobanu V; Gheorghiu M; Ghelerter L; Stroescu O; Stoica G; Papilian M
Med Interna (Bucur); 1969 Oct; 21(10):1211-20. PubMed ID: 5365994
[No Abstract] [Full Text] [Related]
26. Breakdown products of C 3 in human synovial fluids.
Zvaifler NJ
J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
[TBL] [Abstract][Full Text] [Related]
27. The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids.
Ruddy S; Austen KF
Arthritis Rheum; 1970; 13(6):713-23. PubMed ID: 4992981
[No Abstract] [Full Text] [Related]
28. Synovial fluid complement: usefulness in diagnosis and classification of rheumatoid arthritis.
Bunch TW; Hunder GG; Offord K; McDuffie FC
Ann Intern Med; 1974 Jul; 81(1):32-5. PubMed ID: 4834940
[No Abstract] [Full Text] [Related]
29. Effect of intra-articular hydrocortisone on complement in synovial fluid.
Hunder GG; McDuffie FC
J Lab Clin Med; 1972 Jan; 79(1):62-74. PubMed ID: 4621416
[No Abstract] [Full Text] [Related]
30. Immunoglobulin phagocytosis by granulocytes from sera and synovial fluids in various rheumatoid and nonrheumatoid diseases.
Cats A; Lafeber GJ; Klein F
Ann Rheum Dis; 1975 Apr; 34(2):146-55. PubMed ID: 806270
[TBL] [Abstract][Full Text] [Related]
31. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
32. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients.
Santos Savio A; Machado Diaz AC; Chico Capote A; Miranda Navarro J; Rodríguez Alvarez Y; Bringas Pérez R; Estévez del Toro M; Guillen Nieto GE
BMC Musculoskelet Disord; 2015 Mar; 16():51. PubMed ID: 25879761
[TBL] [Abstract][Full Text] [Related]
34. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
35. [Rheumatoid synovial fluid].
Roques CF; Blanc M; Abbal M; Pradère J; Courtin M; Amigues H; Gournié A; Ruffié R
Rev Rhum Mal Osteoartic; 1975 Apr; 42(4):247-52. PubMed ID: 1096285
[TBL] [Abstract][Full Text] [Related]
36. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
Whaley K; Schur PH; Ruddy S
J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
[TBL] [Abstract][Full Text] [Related]
37. [Changes in the synovial membrane in early diagnosed cases of rheumatoid arthritis. II. Immunohistochemical and serological studies].
Emmrich J; Geiler G
Z Rheumatol; 1980; 39(5-6):157-69. PubMed ID: 7415585
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of Tryptophan-related Metabolomic Profile in Rheumatoid Arthritis Synovial Fluid.
Kang KY; Lee SH; Jung SM; Park SH; Jung BH; Ju JH
J Rheumatol; 2015 Nov; 42(11):2003-11. PubMed ID: 26329338
[TBL] [Abstract][Full Text] [Related]
39. Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.
Oleesky DA; Daniels RH; Williams BD; Amos N; Morgan BP
Clin Exp Immunol; 1991 May; 84(2):250-5. PubMed ID: 2025952
[TBL] [Abstract][Full Text] [Related]
40. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA
J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
